I’m not the best person to ask but I’ve been told the Company proposes the specifications for the trial and the Regulatory Agency gives the thumbs up or down.
Why 5 mg? Because the FDA asked for a low dose trial -- which Anavex passed. Apparently some diseases need less dosages than others. Why the bad faith "questions"?